VitroNordic ApS: Financial statements 2023
CVR: 43795260
Source: annual report 2023, Danish Business Authority
20/01/2023 – 31/12/2023
VitroNordic ApS (CVR 43795260) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 116,991 and a net result of DKK -3,403. Equity in the 2023 report amounted to DKK 216,597. The solvency ratio was 53.2%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 116,991
- Profit/Loss
- DKK -3,403
- Equity
- DKK 216,597
- Total Assets
- DKK 406,931
- Employees
- 1
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of January 20, 2023, Jesper Lindhardsen is registered as director of VitroNordic ApS.
As of January 20, 2023, Future Life Holding ApS is registered as an owner of VitroNordic ApS with an ownership share of 100%.
VitroNordic ApS was founded on January 20, 2023.
About VitroNordic ApS
VitroNordic ApS is a Danish company of the type Anpartsselskab based in Hasselager, founded in 2023. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jesper Lindhardsen. The company is owned by Future Life Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 923,732 and a net result of DKK 268,144 compared with DKK 406,363 the year before. Equity in the 2025 report amounted to DKK 891,104.